Featured Content

Q&A With Chris Bakal, PhD: Big Data and Cancer Cell-shape Research

Cancer Therapy Advisor interviewed Dr Bakal about this new approach to analyzing cell shape and its potential to affect breast cancer treatment.

Weight Gain: A Risk Factor for Postmenopausal Breast Cancer

While women who lost more than 5 kg after age 18 were at a 23% reduced risk for breast cancer, those who gained more than ...

ASCO Advance of the Year: Immunotherapy 2.0

The American Society of Clinical Oncology (ASCO) named Immunotherapy 2.0 the "advance of the year."

Triple-negative Breast Cancer: New Strategies for Targeted Therapy

Despite the success of targeted therapy in other cancers, targeted therapy has failed to improve outcomes in triple-negative breast cancer.

Do Clinical Trials Overstate New Cancer Drugs' Survival Benefits?

Experts disagree about whether success in clinical trials translates to success in real world treatment settings.

Breast Cancer Resources

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters